Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2004

View Archived Issues

New p38 kinase inhibitors in early development at BMS

Novel HCV NS5B inhibitors prepared and tested by GSK team

GSK claims 1,2-diazepane-based inhibitors of cathepsin K and other proteases

Chiron presents new melanocortin MC4 agonists for obesity and type 2 diabetes

New tachykinin antagonists for urinary disorders and other uses

Novel beta-secretase inhibitors for AD therapy covered by Merck patent

Milestone reached in Acadia-Allergan agreement

Access Pharmaceuticals signs licensing agreement with Wyeth for OraDisc

BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals establish alliance

BioSante Pharmaceuticals announces DynPort subcontract to develop anthrax vaccines

FDA approves generic Ortho Tri-Cyclen

IND filed for phase I ThermoDox trial for liver cancer

Scripps Research Institute studies confirm utility of NeuGene drugs for SARS

Amylin files IND for PYY compound for obesity

Gilead submits IND for novel HIV protease inhibitor GS-9005

SBIR grant supports late-stage preclinical development of AV-101 for epilepsy

CYT-99-007 enters phase I

International pivotal Trabio study completes enrollment

Progress and plans for Sepracor pipeline

TKT drops plans to obtain U.S. approval for Replagal for Fabry's disease

Expert panel supports the benefits of inhaled corticosteroid use in asthma

Early marker for dementia studied in Down syndrome patients

Widespread use of alternative medicine in prostate cancer patients

Ro-04-6790 supports role of the 5-HT6 receptor in the regulation of cognitive function

Rosuvastatin more effective than atorvastatin in reducing LDL in genetic hypercholesterolemia

Identification of SARS coronavirus functional receptor

Xenical reported to induce weight loss and reduce the risk of type 2 diabetes in obese patients

An anti-IL-5 antibody found safe and effective in patients with HES

A new phase II clinical trial to evaluate Davanat with 5-FU in refractory colorectal cancer

Interferon gamma-1b in idiopathic pulmonary fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...